Compare CRBU & ACU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRBU | ACU |
|---|---|---|
| Founded | 2011 | 1867 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Industrial Machinery/Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.6M | 160.6M |
| IPO Year | 2021 | 1994 |
| Metric | CRBU | ACU |
|---|---|---|
| Price | $1.68 | $48.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $10.75 | ★ $50.00 |
| AVG Volume (30 Days) | ★ 1.8M | 11.0K |
| Earning Date | 05-08-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 1.56% |
| EPS Growth | ★ 3.64 | 1.63 |
| EPS | N/A | ★ 0.24 |
| Revenue | N/A | ★ $196,541,816.00 |
| Revenue This Year | $1.63 | $5.67 |
| Revenue Next Year | $10.93 | $5.25 |
| P/E Ratio | ★ N/A | $198.17 |
| Revenue Growth | N/A | ★ 1.05 |
| 52 Week Low | $1.22 | $35.50 |
| 52 Week High | $3.53 | $47.56 |
| Indicator | CRBU | ACU |
|---|---|---|
| Relative Strength Index (RSI) | 40.66 | 74.41 |
| Support Level | $1.39 | $40.57 |
| Resistance Level | $1.73 | N/A |
| Average True Range (ATR) | 0.13 | 1.58 |
| MACD | -0.01 | 0.40 |
| Stochastic Oscillator | 28.05 | 86.58 |
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.
Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.